FSSAI Advisory On Raising Grievances Related To Central Licences’ Plea

New Delhi : The FSSAI has issued an advisory explaining the matrix for raising grievances/queries related to Central licences’ applications.

The advisory says that in case any food business operator (FBO) is aggrieved by the decision by the Central licensing authority, the matter can be escalated to the concerned Regional Director while in case the FBO further wants to represent the case after receiving comments from the concerned Regional Director or in case no comments was received within 21 days from raising the request to the concerned RD, the FBO can escalate the matter before Executive Director Compliance Strategy at FSSAI Headquarters along with all the relevant communication made with respect to the case till date.

The FSSAI has also advised that communication should be made through registered email id as provided in the licensing application by the FBO.

It is pertinent to note that FSSAI has an online platform, the Food Safety Compliance System (FoSCoS) for issuance of pan-India FSSAI licence and registration and for Central licensing procedures as laid down under the FSS Act, the food authority has approved Central Licensing Authority (CLA).

  • Related Posts

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    New Delhi:  Aurobindo Pharma Ltd on Tuesday said it has set April 23 as the opening date for its Rs 800 crore buyback offer. The closing date for the buyback…

    Boehringer Ingelheim launches AI centre for pharma research in London

    Bengaluru: German drugmaker Boehringer Ingelheim is launching a ​centre for artificial ​intelligence and machine learning in London, it said ​on Monday, as it seeks to expand its AI capabilities in…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Boehringer Ingelheim launches AI centre for pharma research in London

    Boehringer Ingelheim launches AI centre for pharma research in London

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid